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Introduction {#sec1}
============

Reprogramming somatic cells to a pluripotent state can be achieved through ectopic expression of pluripotency transcription factors ([@bib27]). The resulting induced pluripotent stem cells (iPSCs) hold immense promise as tools for research and regenerative therapy. To harness their full potential, studies have scrutinized the molecular mechanisms underpinning reprogramming, and sought to identify factors able to improve this inherently inefficient process ([@bib7], [@bib22]). One well-characterized means of enhancing reprogramming is to inhibit the activity of TP53/TRP53 (hereafter, p53) ([@bib8], [@bib10], [@bib18], [@bib28]). The improved reprogramming efficiency of p53-deficient cells has been attributed to the ability of p53 to trigger senescence and apoptosis. While senescence has been confirmed as a major reprogramming barrier ([@bib2], [@bib10]), the significance of mitochondrial apoptosis is less clear.

Mitochondrial apoptosis is a conserved intrinsic cell death program controlled by interactions between diverse members of the BCL2 protein family, of which there are three functional classes: the pro-survival BCL2-like proteins, the pro-apoptotic BH3-only proteins, and the apoptosis effector proteins, BAK and BAX ([Figure S1](#mmc1){ref-type="supplementary-material"}). In healthy cells, the BCL2-like survival proteins suppress mitochondrial apoptosis by restraining BAK and BAX. However, in response to various forms of cellular stress, including cytokine deprivation, DNA damage, and oncogene activation, BH3-only proteins are triggered to initiate apoptosis both by inhibiting BCL2-like proteins and by directly activating BAK and BAX. Once activated, BAK and BAX oligomerize on the outer mitochondrial membrane to drive its rupture ([@bib6]). The ensuing mitochondrial outer membrane permeabilization (MOMP) results in the efflux of pro-apoptogenic factors, including cytochrome *c*, to the cytosol. At this point, the cell is irreversibly committed to death, and a cascade of proteolytic caspases is activated that brings about the ordered demolition of cellular components.

Deciphering the role of apoptosis in cellular processes can be complicated by the fact that each of the three classes of BCL2 family proteins comprises multiple family members, and that each of these proteins has a certain propensity to interact with and regulate the others ([@bib4], [@bib5], [@bib30]). As such, there is a large degree of functional overlap and redundancy within the family. Importantly for our studies, however, BAK and BAX are the only two BCL2 family members able to drive MOMP, and in their combined absence, the mitochondrial apoptosis pathway is completely abolished ([@bib17]).

Thus far, attempts to resolve the role, if any, of mitochondrial apoptosis during reprogramming have primarily focused on upstream regulators, including BCL2, the archetypal pro-survival BCL2 family member, and PUMA, a p53-regulated BH3-only protein ([@bib10], [@bib13], [@bib16]). These studies have produced conflicting data, with two studies reporting significant enhancement of reprogramming efficiency when apoptosis was blocked, either through BCL2 overexpression or PUMA depletion ([@bib10], [@bib16]), and another reporting that PUMA depletion promoted reprogramming under OKS but not OKSM conditions ([@bib13]).

To directly evaluate the influence of apoptosis on the efficiency of reprogramming, we used mouse embryonic fibroblasts (MEFs) lacking both BAK and BAX. Such cells provide a definitive model system in which to study cellular processes in the absence of mitochondrial apoptosis ([@bib17]). Here, we report that *Bak*^*−/−*^;*Bax*^*−/−*^ MEFs undergo reprogramming with markedly increased efficiency compared with their wild-type (WT) counterparts in OKSM, but not OKS conditions. Remarkably, they traverse this process without incurring significantly increased genomic instability. Our data conclusively demonstrate that mitochondrial apoptosis imposes a strong barrier to OKSM-mediated iPSC induction, and that this roadblock is MYC-dependent. While the overall efficiency of iPSC derivation is markedly improved with ectopic *Myc* expression, the heightened sensitivity to apoptosis curtails its full benefit in reprogramming.

Results and Discussion {#sec2}
======================

Mitochondrial Apoptosis: A Barrier to iPSC Derivation by OKSM Expression {#sec2.1}
------------------------------------------------------------------------

To examine the role of mitochondrial apoptosis in reprogramming, WT and *Bak*^*−/−*^*;Bax*^*−/−*^ MEFs were transduced with lentiviral OKSM factors. After 18 days of reprogramming, *Bak*^−/−^;*Bax*^−/−^ MEFs yielded alkaline phosphatase (AP)-positive colonies ([Figure 1](#fig1){ref-type="fig"}A) that were morphologically indistinguishable from those derived from WT MEFs ([Figure S2](#mmc1){ref-type="supplementary-material"}A). Moreover, they displayed markedly improved reprogramming efficiency compared with WT MEFs, as measured by AP activity ([Figure 1](#fig1){ref-type="fig"}B) and verified by immunocytochemical staining of the pluripotency marker, NANOG ([Figure S2](#mmc1){ref-type="supplementary-material"}B). Meanwhile, deficiency in either BAK or BAX alone did not significantly affect the yield of AP-positive colonies ([Figures 1](#fig1){ref-type="fig"}A and 1B). This is consistent with their functional redundancy in mediating MOMP, and proves that the increased reprogramming efficiency of *Bak*^−/−^;*Bax*^−/−^ MEFs is attributable to attenuation of mitochondrial apoptosis.Figure 1Enhanced Production of iPSCs in the Absence of Apoptosis Yields Fully Pluripotent Cells(A) Alkaline phosphatase (AP) staining of WT, *Bak*^*−/−*^, *Bax*^*−/−*^*,* and *Bak*^−/--^;*Bax*^−/--^ MEFs at 18 days post transduction with OKSM reveals enhanced reprogramming efficiency in *Bak*^−/--^;*Bax*^−/--^ cells.(B) Quantification of AP-positive colonies generated by each genotype relative to WT. Values shown are mean ± SD. ^∗∗∗∗^p \< 0.0001, n ≥ 5 independent experiments, each with an independently derived MEF line. n.s., not significant.(C) Expression of the pluripotency markers SSEA1, NANOG, and OCT4 in independent *Bak*^*−/−*^, *Bax*^*−/−*^ iPSC colonies passaged at least five times. During this time, the colonies maintained a characteristic iPSC morphology (see also [Figure S2](#mmc1){ref-type="supplementary-material"}).(D) *Bak*^*−/−*^;*Bax*^*−/−*^ embryoid bodies were produced from isolated iPSCs by the hanging drop method. These were cultured on adhesive surfaces for 2 weeks prior to staining for differentiation markers representing the three germ layers: α1 fetoprotein (endoderm), α smooth muscle actin (mesoderm), and βIII tubulin (ectoderm).(E) Hematoxylin and eosin-stained sections of *Bak*^*−/−*^;*Bax*^*−/−*^ iPSC-derived teratomas reveals differentiated tissues representative of all three germ layers.Scale bars, 20 μm.

To further assess the pluripotency of colonies generated from *Bak*^−/−^;*Bax*^−/−^ MEFs, we cultured them over at least five passages to confirm their self-renewal capacity, during which time they maintained a shiny, rounded morphology and expression of the pluripotency markers SSEA1, NANOG, and OCT4 ([Figure 1](#fig1){ref-type="fig"}C). These observations are consistent with those reported for embryonic stem cells deficient in BAK and BAX ([@bib29]).

Next, to assess the differentiation capacity of *Bak*^−/−^;*Bax*^−/−^ iPSCs, we generated embryoid bodies by the hanging drop method. Cells from three independent lines spontaneously differentiated into cells representative of all three germ layers ([Figure 1](#fig1){ref-type="fig"}D). Finally, we investigated the *in vivo* differentiation capacity of the *Bak*^−/−^;*Bax*^−/−^ iPSC lines by injecting them subcutaneously into mice. The resulting teratomas contained tissues derived from all three germ layers ([Figure 1](#fig1){ref-type="fig"}E).

Elevated Caspase-3/7 Activity during OKSM Reprogramming Suggests MYC-Stimulated Apoptosis Forms a Significant Barrier to Reaching Pluripotency {#sec2.2}
----------------------------------------------------------------------------------------------------------------------------------------------

Having observed that *Bak*^−/−^;*Bax*^−/−^ MEFs reprogrammed more efficiently upon the expression of OKSM factors, we next tested whether this would also hold true when MEFs were reprogrammed without MYC, given its propensity to promote apoptosis. When MEFs were reprogrammed with only OKS, there was a striking decrease in iPSC formation compared with MEFs reprogrammed with OKSM ([Figure 2](#fig2){ref-type="fig"}A), consistent with previous reports ([@bib20]). However, there was no significant difference in reprogramming efficiencies between *Bak*^*−/−*^*;Bax*^*−/−*^ and WT cultures ([Figure 2](#fig2){ref-type="fig"}A); this suggests that in the absence of ectopic MYC expression, apoptosis does not significantly limit reprogramming. Conversely, we hypothesize that ectopic MYC expression drives elevated levels of apoptosis that in turn limits the efficiency of OKSM reprogramming.Figure 2Apoptosis Is a *Myc*-Induced Reprogramming Roadblock(A) *Bak*^*−/−*^;*Bax*^*−/−*^ MEFs transduced with OKSM produced significantly more AP-positive colonies compared with WT MEFs. In OKS conditions, WT and *Bak*^*−/−*^;*Bax*^*−/−*^ MEFs produced significantly fewer colonies, and there was no significant difference (n.s.) between them.(B) WT and *Bak*^*−/−*^;*Bax*^*−/−*^ MEFs were treated for 6 hr with S63845 and A-1331852 to inhibit the pro-survival factors, MCL1 and BCLx, respectively. At this point, all WT cells exhibited high caspase-3/7 activity. In contrast, *Bak*^*−/−*^;*Bax*^*−/−*^ MEFs exhibited negligible caspase-3/7 activity, even in the presence of S63845 and A-1331852.(C) Caspase-3/7 assays were conducted every 3 days during the first 12 days of reprogramming in OKSM and OKS conditions. WT MEFs transduced with OKSM factors exhibited significantly higher caspase-3/7 activity compared with WT MEFs transduced with OKS. Meanwhile, *Bak*^*−/−*^;*Bax*^*−/−*^ MEFs exhibited very low caspase-3/7 activity throughout the experiment, independently of whether they were transduced with OKSM or OKS.(D) Proposed model: exogenous MYC enhances reprogramming by inducing biosynthetic changes favorable to reprogramming, including increased transcription, translation, and a switch from oxidative phosphorylation to a glycolytic mode of energy production. However, exogenous MYC also raises an apoptosis barrier, which is abolished in *Bak*^*−/−*^;*Bax*^*−/−*^ cells.Values are mean ± SD, ^∗∗∗∗^p \< 0.0001, n ≥ 5 independent experiments, each with an independently derived MEF line.

To determine whether apoptosis was indeed elevated during OKSM relative to OKS reprogramming, we measured caspase-3/7 activity over the first 12 days of reprogramming using the Caspase-Glo 3/7 Assay System (Promega). To establish a reference for these assays, we induced apoptosis in 100% of MEFs by treating them with small molecule inhibitors of the pro-survival proteins, MCL1 (S63845; [@bib12]) and BCLXL for 6 hr (A-1331,852; [@bib14]). As expected, robust caspase-3/7 activity was elicited in WT but not *Bak*^−/−^;*Bax*^−/−^ MEFs ([Figure 2](#fig2){ref-type="fig"}B). WT MEF cultures reprogrammed with OKSM exhibited elevated caspase-3/7 activity that peaked at approximately 10% of the level observed in the apoptotic reference sample ([Figure 2](#fig2){ref-type="fig"}C). Furthermore, caspase-3/7 activity was consistently higher in WT MEFs reprogrammed with OKSM compared with OKS throughout the duration of the experiment ([Figure 2](#fig2){ref-type="fig"}C). In contrast, we detected very low caspase-3/7 activity in reprogramming *Bak*^−/−^;*Bax*^−/−^ MEFs ([Figures 2](#fig2){ref-type="fig"}B and 2C).

These data are consistent with prior findings that ectopic MYC expression sensitizes cells to apoptosis ([@bib19], [@bib23]) and lead us to conclude that mitochondrial apoptosis constitutes a major barrier to reprogramming when MYC is included as one of the pluripotency factors ([Figure 2](#fig2){ref-type="fig"}D). Thus, while MYC enhances overall reprogramming efficiency through reinforcing cell proliferation and growth, this is mitigated in part by an increase in BAK/BAX-mediated apoptosis.

p53-Mediated Apoptosis Is Not a Major Barrier to OKS Reprogramming {#sec2.3}
------------------------------------------------------------------

Previous studies have established p53 as a barrier to both OKSM and OKS-mediated reprogramming. While p53 drives a variety of cellular responses, it is primarily thought to hinder iPSC derivation by provoking senescence and apoptosis. Based on our observations that apoptosis was not a major barrier to OKS-mediated reprogramming ([Figure 2](#fig2){ref-type="fig"}A), we reasoned that deficiency of BAK and BAX would add little further advantage to *p53*-deficient cultures in OKS conditions. To test this, we introduced *p53* mutations in primary MEFs using CRISPR/Cas9 targeting. Western blots confirmed that single-guide RNAs (sgRNAs) targeting either exon 4 or exon 5 of *p53* were highly effective at ablating *p53* expression ([Figure 3](#fig3){ref-type="fig"}A; [@bib1]). When reprogrammed with OKS, WT and *Bak*^−/−^;*Bax*^−/−^ MEFs expressing Cas9 together with sgRNA targeting *p53* both formed AP-positive iPSCs more efficiently than controls expressing only Cas9 ([Figure 3](#fig3){ref-type="fig"}B). However, we observed no significant difference between the reprogramming capacity of WT or *Bak*^*−/−*^;*Bax*^*−/−*^ MEFs in the absence of p53 ([Figure 3](#fig3){ref-type="fig"}B). This confirms that when mitochondrial apoptosis is blocked in OKS conditions, other p53-driven responses, such as senescence, are likely to pose the primary reprogramming roadblocks.Figure 3p53-Mediated Apoptosis Is Not a Barrier to OKS Reprogramming(A) Western blot of p53 protein in primary MEFs expressing Cas9 and sgRNAs targeting either exon 4 or 5 confirms *p53* knockout in both examples. Cells were treated with doxorubicin to increase p53 protein to detectable levels. In the final lane, transformed MEFs overexpressing p53 were used as a positive control.(B) WT *and Bak*^*−/−*^*;Bax*^*−/−*^ MEFs expressing Cas9 alone or together with sgRNA targeting *p53* were reprogrammed with OKS for 18 days, at which point AP-positive colonies were enumerated. The data are presented as efficiency relative to the WT-Cas9 control in each experiment. Bars represent the mean values for n ≥ 3 independent experiments, each with an independently derived MEF line. n.s., not significant.

Genomic Integrity of *Bak*^−/−^;*Bax*^−/−^ iPSCs Is Comparable with that of WT iPSCs {#sec2.4}
------------------------------------------------------------------------------------

Apoptosis is sometimes regarded as a mechanism to safeguard genome integrity. A block in mitochondrial apoptosis might therefore have deleterious effects on genomic integrity during reprogramming. To investigate this, we examined DNA double-strand breaks and copy number alterations (CNAs) in several independent *Bak*^−/−^;*Bax*^−/−^ iPSC lines that had been propagated for two or more passages. Using γH2AX as a marker, we quantified DNA double-strand breaks and found no significant difference between WT and *Bak*^−/−^;*Bax*^−/−^ iPSC lines ([Figures 4](#fig4){ref-type="fig"}A and 4B). Furthermore, using low pass whole genome sequencing, we observed no significant difference in the number of CNAs in iPSC clones derived from *Bak*^−/--^;*Bax*^−/--^ MEFs compared with those derived from WT MEFs ([Figures 4](#fig4){ref-type="fig"}C, 4D, [S3](#mmc1){ref-type="supplementary-material"}A, and S3B). Although this method is not sensitive enough to detect single-nucleotide aberrations that may occur during reprogramming, these results are consistent with reports that the process of reprogramming is not inherently mutagenic ([@bib31]) and that embryonic stem cells lacking BAK and BAX maintain a normal karyotype ([@bib29]). In contrast, iPSC clones derived from *p53*-deficient MEFs exhibited a significantly higher number of CNAs compared with the *Bak*^−/--^;*Bax*^−/--^ and WT groups ([Figures 4](#fig4){ref-type="fig"}C, 4D, and [S3](#mmc1){ref-type="supplementary-material"}C). In summary, MEFs unable to execute mitochondrial apoptosis display enhanced reprogramming capacity with OKSM without notable changes in genome stability.Figure 4Enhanced Production of iPSCs in the Absence of Apoptosis Yields Cells with DNA and Genome Stability Comparable with that of WT iPSCsManually picked iPSC clones were cultured prior to assessment of genomic stability.(A) Representative confocal images of iPSC colonies (passage 5) stained for γH2AX, which marks DNA double-strand breaks. Scale bars, 20 μm.(B) Quantification of γH2AX foci was automated using γ-irradiated iPSC colonies as a positive control to set the threshold for fluorescence intensity. The average number of γH2AX foci in the nuclei of WT and *Bak*^−/−^;*Bax*^−/−^ iPSCs is not significantly different. For this experiment, independent MEF lines derived from different embryos (n = 4 for WT; n = 3 for *Bak*^−/−^;*Bax*^−/−^) were reprogrammed and corresponding iPSC lines established. Each point represents analysis of 1 colony (15--30 nuclei), with 9--12 colonies analyzed per independently derived iPSC line. Bars represent the mean values for each genotype. n.s., not significant.(C) Quantification of CNAs in iPSC clones (passage 2) derived from *Bak*^−/−^;*Bax*^−/−^ MEFs compared with those derived from WT and *p53*^*−/−*^ MEFs. There is no significant difference in the number of CNAs in WT and *Bak;Bax* DKO parental MEFs and their clonal iPSC derivatives. In contrast, iPSC clones derived from *p53*^−/−^ MEFs exhibit a significantly higher number of CNAs (n = 6 iPSC clones derived from a single MEF line/genotype). Bars represent the mean values for each genotype. ^∗∗^p \< 0.01, Mann-Whitney *U* test.(D) A heatmap detailing CNAs on autosomal chromosomes (1--19, labeled at top) in MEF and clonal iPSC derivatives. Copy number is shown with a color scale, ranging from one to three copies (from blue to red). The genomic position of targeted genes is indicated along the bottom, and these loci are highlighted in the relevant samples (dashed boxes). See also [Figure S3](#mmc1){ref-type="supplementary-material"}.

Conclusion {#sec2.5}
----------

Our observations lead us to conclude that MYC-driven BAK/BAX-mediated mitochondrial apoptosis presents a significant roadblock to OKSM reprogramming. While the overall effect of forced MYC expression favors reprogramming by regulating a broad range of biosynthetic processes required for enhanced cell growth and proliferation, including transcription, translation, and energy production ([@bib21], [@bib24], [@bib26]), its propensity to sensitize cells to mitochondrial apoptosis partly mitigates these advantages ([Figure 2](#fig2){ref-type="fig"}D). In our hands, inhibiting apoptosis in *Bak*^−/−^;*Bax*^−/−^ iPSCs does not compromise their capacity to differentiate into lineages derived from all three germ layers, both *in vitro* and *in vivo*, nor have an adverse effect on genome integrity.

In conclusion, our study shows that harnessing the reprogramming-enhancing effects of MYC while selectively inhibiting its apoptotic response may be a useful strategy for efficient generation of iPSCs. We predict that studies aimed at improving our understanding of reprogramming factor stoichiometry and the specific downstream effectors of MYC will most likely make important contributions to improved iPSC derivation and application in the future.

Experimental Procedures {#sec3}
=======================

Mouse Embryonic Fibroblasts {#sec3.1}
---------------------------

*Bak*^*−/−*^ mice (gift of Craig Thompson; [@bib17]), *Bax*^*−/−*^ mice (Jackson Laboratory; [@bib11]) were backcrossed to C57BL/6 mice for \>10 generations, then inter-crossed to generate *Bak*^*−/−*^;*Bax*^*−/−*^ double-knockout (DKO) E13.5 embryos to obtain MEFs. WT MEFs were derived from C57BL/6 mice. *p53*^*−/−*^ MEFs ([@bib9]) were a gift of Anne Voss. All procedures performed on mice were reviewed and approved by the Animal Ethics Committee of the Walter and Eliza Hall Institute of Medical Research.

Generation of MEFs Containing *p53* Mutations for OKS Reprogramming {#sec3.2}
-------------------------------------------------------------------

MEFs were transduced with a lentivirus encoding doxycycline-inducible mCherry-Cas9 either alone or together with lentiviruses encoding a GFP expression marker and sgRNA targeting either exon 4 or 5 of *p53* ([@bib1]). mCherry positive or mCherry/GFP double-positive cells were then sorted on a BD FACSAria III, and treated with doxycycline (2 μg/mL) for 48 hr before reprogramming.

Generation of Lentiviruses {#sec3.3}
--------------------------

HEK293T cells were plated at a density of 3 × 10^6^ cells/9 cm plate the day prior to transfection. Plasmids encoding lentiviral packaging components, the ecotropic envelope glycoprotein, and the reprogramming cassette OKSM ([@bib25]) or OKS ([@bib3]) were introduced into HEK293T cells with FuGENE 6 Transfection Reagent (Promega) according to the manufacturer\'s instructions. The medium was replaced 24 hr post transfection. Viral supernatants were collected from cells at 48 and 72 hr post transfection, filtered (0.45 μm), and added to MEFs alongside polybrene (5 μg/mL).

Mitochondrial Apoptosis Assay {#sec3.4}
-----------------------------

At 3-day intervals following transduction of MEFs with OKS or OKSM, we collected, pooled, and lysed adherent and non-adherent cells in PBS containing NP-40 (1%). Protein content was quantitated with a BCA assay, and caspase activity was measured with the Caspase-Glo 3/7 Assay System (Promega). Luminescence readings were divided by the protein content of the lysate to give a measure of caspase activity per milligram of protein, thereby correcting for the increase in cell number over the duration of the assay. To provide a positive control, we treated WT MEFs with S63845 (SYNthesis Med Chem) and A-1331852 (kind gift of Jean-Marc Garnier and Guillaume Lessene) to specifically inhibit two pro-survival Bcl2 family molecules, MCL1 and BCLx, respectively. This treatment produced synchronous apoptosis, which was morphologically evident in 100% cells after 6 hr. We designated the corresponding luminescence as the maximum expected value from the assay if all cells undergo apoptosis. Thus, at day 6, when WT-OKSM values peak at ∼10% of this value, we extrapolated this to mean that ∼10% of cells in the culture are apoptotic.

Detection of CNAs {#sec3.5}
-----------------

Colonies of WT, *Bak*^−/−^;*Bax*^−/−^, and *p53*^−/−^ iPSCs were picked and propagated for two passages. Genomic DNA was isolated from six clones of each genotype, plus the corresponding MEFs from which the clones were derived, using a DNeasy blood and tissue kit (Qiagen). Libraries were prepared from sheared genomic DNA (∼300 bp; 4 ng per sample) using a Truseq DNA sample preparation kit (Illumina). All 21 samples were applied to one lane of a NextSeq run, yielding ∼4 million × 81 bp paired-end reads per library. Reads were aligned to *mm10* with BWA 0.7.15-r1140 ([@bib15]) and analyzed with superFreq 0.9.21 (<https://github.com/ChristofferFlensburg/superFreq>) over 100 kbp bins, with increased sensitivity for CNAs with systematic variance set to 0.01. Limma-voom was used to estimate log fold change (LFC) and variance, which forms the input to a hierarchical segmentation of the genome. SuperFreq calls CNAs by comparing with a set of reference samples, which in this case comprised the WT colonies. When analyzing individual WT colonies, we compared them with a reference pool that included all other WT samples (i.e., the test sample was excluded from the reference pool). Using the superFreq calls, we counted copy number segments with an absolute LFC larger than 7% stretching over at least 10 Mbp.

Statistical Analysis {#sec3.6}
--------------------

Graphs and p values were obtained with GraphPad Prism 6. Pairwise comparisons were made using Student\'s t test.

Author Contributions {#sec4}
====================

E.J.Y.K. designed and conducted experiments, collected and assembled data, analyzed and interpreted data, wrote the paper, and approved the final manuscript. M.-L.A. designed and conducted experiments, analyzed and interpreted data, provided study materials, edited the paper, and approved the final manuscript. C.F. designed and conducted experiments, collected and assembled data, analyzed and interpreted data, edited the paper, and approved the final manuscript. I.J.M. designed experiments, provided study materials, analyzed and interpreted data, read the paper, and approved the final manuscript. F.-S.G. conducted experiments, read the paper, and approved the final manuscript. J.F. conducted experiments, read the paper, and approved the final manuscript. D.C.S.H. conceived and designed experiments, provided financial support and study materials, analyzed and interpreted data, edited the paper, and approved the final manuscript. M.F.v.D. designed and conducted experiments, provided study materials, collected and assembled data, analyzed and interpreted data, wrote the paper, and approved the final manuscript. J.K.H. conceived and designed experiments, provided financial support and study materials, analyzed and interpreted data, wrote the paper, and approved the final manuscript.

Supplemental Information {#app2}
========================

Document S1. Supplemental Experimental Procedures, Figures S1--S3, and Tables S1 and S2Document S2. Article plus Supplemental Information

We thank Sue Mei Lim for assistance with teratoma formation assays, Siddhartha Deb for pathological analysis, Jose Polo for discussions, Marco Herold for the validated *Cas9* and guide RNA constructs, and Lachlan Whitehead and Stephen Mieruszynski for image analysis. This research was supported by the Australian National Health and Medical Research Council (1043092, 1022870, 487922) and Ludwig Cancer Research, with operational infrastructure grants from the Australian Federal Government (IRISS) and the Victorian State Government (OIS).

Supplemental Information includes Supplemental Experimental Procedures, three figures, and two tables and can be found with this article online at [https://doi.org/10.1016/j.stemcr.2017.12.019](10.1016/j.stemcr.2017.12.019){#intref0015}.

[^1]: Co-senior author
